Kitasamicin

Kitasamicin

Klinički podaci
AHFS/Drugs.com	Monografija
Identifikatori
CAS broj	39405-35-1
ATCvet kod	QJ01FA93
PubChem[1][2]	5282189
ChEMBL[3]	CHEMBL1909061 Y
Hemijski podaci
Formula	C35H59NO13
Mol. masa	701,842
SMILES	eMolekuli & PubHem
InChI InChI=1S/C35H59NO13/c1-19-16-23(14-15-37)31(32(44-8)25(39)17-26(40)45-20(2)12-10-9-11-13-24(19)38)49-34-29(41)28(36(6)7)30(21(3)47-34)48-27-18-35(5,43)33(42)22(4)46-27/h9-11,13,15,19-25,27-34,38-39,41-43H,12,14,16-18H2,1-8H3/b10-9+,13-11+/t19-,20-,21-,22+,23+,24+,25-,27+,28-,29-,30-,31+,32+,33+,34+,35-/m1/s1 Key: XYJOGTQLTFNMQG-KJHBSLKPSA-N Y
Sinonimi	Turimycin
Farmakoinformacioni podaci
Trudnoća	?
Pravni status

Kitasamicin je organsko jedinjenje, koje sadrži 35 atoma ugljenika i ima molekulsku masu od 701,842 Da.

1. ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
2. ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
3. ↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit